Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

OTHER 41INDUSTRY 12NETWORK 9NIH 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colonic Neoplasms 70Rectal Neoplasms 67Colorectal Neoplasms 61Breast Neoplasms 26Pancreatic Neoplasms 15Head and Neck Neoplasms 13Neoplasm Metastasis 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Unspecified Adult Solid Tumor, Protocol Specific 9Stomach Neoplasms 8Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Adenocarcinoma Of Esophagus 5Ovarian Neoplasms 4Kidney Neoplasms 4Gallbladder Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Oropharyngeal Neoplasms 3Neoplasms 3Nasopharyngeal Neoplasms 3Lymphoma 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Anus Neoplasms 3Uterine Cervical Dysplasia 2Salivary Gland Neoplasms 2

Interventions

Paclitaxel 6Radiotherapy 5Fluorouracil 5Cisplatin 4Taxes 3Specimen Handling 3Radiation 2Erlotinib Hydrochloride 2Endoscopy, Digestive System 2Endoscopy 2trastuzumab biosimilar HLX02 1rubitecan 1romidepsin 1oblimersen 1obeticholic acid 1cixutumumab 1bryostatin 1 1alvocidib 1adavosertib 1Trastuzumab 1Ramucirumab 1Radiofrequency Ablation 1PF-05280014 1Oxaliplatin 1Ontruzant 1Ogivri 1Nivolumab 1Neoadjuvant Therapy 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NIH × Adenocarcinoma Of Esophagus × Fluorouracil × Clear all
NCT00064259 2021-02-17

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

National Cancer Institute (NCI)

Phase 1/2 Terminated
15 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00005607 2013-12-19

Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus

National Cancer Institute (NCI)

Phase 2 Unknown
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00041262 2013-08-12

Combination Chemotherapy in Treating Patients With Esophageal Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
1,300 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00002884 2013-08-07

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

National Cancer Institute (NCI)

Phase 3 Unknown
326 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00004257 2013-03-26

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

National Cancer Institute (NCI)

Phase 1 Completed
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡